本帖最后由 StephenW 于 2013-6-16 16:27 编辑
回复 tonychant 的帖子
Reported by Jules Levin APASL Liver Week
Singapore, June 6–10, 2013 Chan HLY, Ahn SH, Chang TT, Peng CY, Wong D,Coffin CS, Lim SG, Chen PJ, Janssen HLA,Marcellin P, Serfaty L, Zeuzem S, Hu W, Critelli L, Lopez-Talavera JC, Cooney E
CONCLUSIONS
■ Significantly greater early (Weeks 2–16) decline from baseline in HBV DNA with Lambda vs alfa
■ Significantly greater change from baseline in qHBsAg through Week 24 with Lambda vs alfa
■ Comparable HBeAg loss and seroconversion rates through Week 24
–Week 72 data awaited to assess sustained off-treatment serologic response rates across the two groups
■ Rate of ALT normalization at Week 24 was numerically higher for alfa than Lambda
–Explained by the higher rate of early-onset ALT elevations seen with Lambda
结论
■λ显着提高早期(2-16周)HBV DNA从基线下降
■λ显着qHBsAg变化,从基准通过24周
■可比HBeAg消失和血清转换率,通过24周
等待第72周的数据,评估持续治疗血清学应答率在两个组
■第24周时,ALT复常率 α数值高于λ
解释:λ 的早发性ALT升高率较高
|